Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Patients and data tracking

Profile pics of Priti and Tijana

Genesis Research Insights & Evidence webinar 20 Oct: Reserve your place!

Join Priti Jhingran of Genesis Research and Tijana Ignjatovic of Market Access Transformation (MAT) for their webinar 'Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to...

Genesis Research Group

Attendee Experience Designer

WRG Launches Attendee Experience Design (AXD) Unit

WRG, the events and experiential division of The Creative Engagement Group, launches Attendee Experience Design (AXD) Unit. Combining Behavioural Science, Data Insights, and Digital and Live UX in One Unit

The Creative Engagement Group

- PMLiVE

#Wellbeing Week: Let’s tackle pressure

Hear from Paul Hutchings, founder of foxandcat.online, with tips and advice to help your comms team thrive under pressure

Fox&Cat

- PMLiVE

The promised land of gene therapy: Commercialization of novel gene-editing technology in beta-thalassemia

With transformative treatments that leverage CRISPR technology, there are many challenges to overcome throughout the journey of development through to patient access. We interviewed a researcher at a top 20...

Avalere Health

- PMLiVE

The future of medtech is in the past

By Ivor Campbell

- PMLiVE

Michael J Fox Foundation awards $4.9m grant to Muna Therapeutics

The grant will support the development of the company’s disease modifying therapy for Parkinson's disease

- PMLiVE

NHS Scotland to offer Jyseleca for patients with moderate rheumatoid arthritis

More than 40,000 people in Scotland live with RA and an estimated 35% of those will have moderate disease activity

- PMLiVE

Gilead’s Trodelvy granted FDA priority review for metastatic breast cancer

Phase 2 study results showed a 34% reduction in risk of disease progression or death

- PMLiVE

Abivax enrols first patient in global phase 3 programme with obefazimod in ulcerative colitis

So far, more than 460 study sites have been qualified to take part in the phase 3 trials

- PMLiVE

Envisioning a healthier every day, for every woman

By Sandy Lindsey

- PMLiVE

GSK’s Boostrix approved by FDA for use during pregnancy to prevent whooping cough in infants

4.2% of the cases of pertussis reported in the US in 2021 were in infants younger than six months

- PMLiVE

Biogen doses first patient with litifilimab in cutaneous lupus erythematosus study

The phase 2/3 study is expected to be conducted at approximately 238 sites worldwide

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links